🇺🇸 FDA

Drug profile · INN

dextromethorphan polistirex

DEXTROMETHORPHAN POLISTIREX

approved
US status
approved
Patents linked
0
News articles
0

Quick answer

dextromethorphan polistirex (DEXTROMETHORPHAN POLISTIREX) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN dextromethorphan polistirex
Brand DEXTROMETHORPHAN POLISTIREX
Route ORAL
Formulation SUSPENSION, EXTENDED RELEASE

Frequently asked questions

What is dextromethorphan polistirex?

dextromethorphan polistirex (DEXTROMETHORPHAN POLISTIREX) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for dextromethorphan polistirex?

DEXTROMETHORPHAN POLISTIREX is a marketed brand name for dextromethorphan polistirex. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of dextromethorphan polistirex?

dextromethorphan polistirex has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.